“Uncovering the Truth: Intellia Therapeutics Inc. Under Investigation for Possible Securities Violations”
Levi & Korsinsky Investigates Intellia Therapeutics, Inc. for Possible Securities Law Violations February 1, 2025 NEW YORK, NY / ACCESS Newswire Levi & Korsinsky has announced that it is currently investigating Intellia Therapeutics, Inc. (NASDAQ:NTLA) for potential violations of federal securities laws. The investigation comes in response to a press release issued by Intellia on…